Ginkgo Won't Prevent Alzheimer's, Study Finds - but Yes Weed Can

Marijuana is the Most Effective Herbal Remedy Known to Mankind Marijuana remains your best bet for protecting yourself from, or even treating yourself for, Alzheimer's disease! Here is a report that one herbal remedy, Ginko biloba has no anti-Alzheimer's activity, followed by excerpts from a Scripps study that proves that THC, the psychoactive cannabinoid in marijuana, is the best-know remedy for the pathology of Alzheimer's disease. But the federal government will not fund nor permit studies on how to utilize this compound to help us because it is so involved with maintaining the war on marijuana in order to fill prison cells for the prison-industrial complex. Even if you've never thought of smoking marijuana and are totally disinterested in anything having to do with "High Times" culture, you must understand that the prohibition of cannabis/marijuana is harming you by preventing you and your loved ones from having safe access to remedies that can protect us all from terrible illnesses.

WEDNESDAY, Sept. 5 HealthDay News -- Yet another study, this one by French researchers, finds that the herbal supplement ginkgo biloba won't prevent or delay Alzheimer's disease."One would hope that this would be the final nail in the coffin for ginkgo," said Dr. Sam Gandy, the Mount Sinai chair in Alzheimer's Disease Research and associate director of the Mount Sinai Alzheimer's Disease Research Center in New York City. "Dead and buried. Enough said. Time to move on."The report is published in the Sept. 6 online edition of The Lancet Neurology.

via Ginkgo Won't Prevent Alzheimer's, Study Finds - US News and World Report.

From the Scripps Research Institute, August 9, 2006: We demonstrate that the active component of marijuana, Δ9-tetrahydrocannabinol (THC), competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation, the key pathological marker of Alzheimer's disease. Computational modeling of the THC-AChE interaction revealed that THC binds in the peripheral anionic site of AChE, the critical region involved in amyloidgenesis. Compared to currently approved drugs prescribed for the treatment of Alzheimer's disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.